APO Research
Talk to an analyst

APO RESEARCH · REPORT

Macrolide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Macrolide Drugs Market Outlook and Growth Opportunities 2026

22 December 2025201 pages

Choose your research edition.

Industry ResearchMacrolide Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Macrolide Drugs Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Macrolide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Macrolide Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Macrolide Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Macrolide Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Macrolide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Macrolide Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Macrolide Drugs market include Teva Pharmaceutical Industries, Sanofi, Merck & Co., Mylan, Pfizer, Fresenius Kabi, WOCKHARDT, Tacorolimus and Sirolimus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Macrolide Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Macrolide Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Macrolide Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Macrolide Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Macrolide Drugs Segment by Company

Teva Pharmaceutical Industries

Sanofi

Merck & Co.

Mylan

Pfizer

Fresenius Kabi

WOCKHARDT

Tacorolimus

Sirolimus

Sandoz International

Neo Química

Macrolide Pharmaceuticals

Gland Pharmm

Eli Lilly & Co.

Akorn

Abbott Laboratories

Macrolide Drugs Segment by Type

14-Membered Ring Agents

15-Membered Ring Agents

16-Membered Ring Agents

Ketolides

Macrolide Drugs Segment by Application

Clinics

Hospitalshospital Pharmacies

Hospitals

Online Pharmacies

Retail Pharmacies

Macrolide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Macrolide Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Macrolide Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Macrolide Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Macrolide Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Macrolide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Macrolide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Macrolide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Macrolide Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Macrolide Drugs industry.

Chapter 3: Detailed analysis of Macrolide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Macrolide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Macrolide Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Macrolide Drugs Industry Trends Table 2. Macrolide Drugs Industry Drivers Table 3. Macrolide Drugs Industry Opportunities and Challenges Table 4. Macrolide Drugs Industry Restraints Table 5. Global Macrolide Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Macrolide Drugs Revenue Share by Company (2021-2026) Table 7. Global Macrolide Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Macrolide Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Macrolide Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Macrolide Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Macrolide Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Macrolide Drugs Company, Product Type & Application Table 13. Global Macrolide Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Macrolide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 14-Membered Ring Agents Table 18. Significant Companies of 15-Membered Ring Agents Table 19. Significant Companies of 16-Membered Ring Agents Table 20. Significant Companies of Ketolides Table 21. Global Macrolide Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Macrolide Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Macrolide Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Macrolide Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Macrolide Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Macrolide Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Macrolide Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Macrolide Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Macrolide Drugs Sales Value Share by Type (2021-2026) Table 30. Global Macrolide Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinics Table 32. Significant Companies of Hospitalshospital Pharmacies Table 33. Significant Companies of Hospitals Table 34. Significant Companies of Online Pharmacies Table 35. Significant Companies of Retail Pharmacies Table 36. Global Macrolide Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Macrolide Drugs Sales Volume by Application (2021-2026) & (k units) Table 38. Global Macrolide Drugs Sales Volume by Application (2027-2032) & (k units) Table 39. Global Macrolide Drugs Sales Volume Share by Application (2021-2026) Table 40. Global Macrolide Drugs Sales Volume Share by Application (2027-2032) Table 41. Global Macrolide Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Macrolide Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Macrolide Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Macrolide Drugs Sales Value Share by Application (2021-2026) Table 45. Global Macrolide Drugs Sales Value Share by Application (2027-2032) Table 46. Global Macrolide Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Macrolide Drugs Sales by Region (2021-2026) & (k units) Table 48. Global Macrolide Drugs Sales Market Share by Region (2021-2026) Table 49. Global Macrolide Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Macrolide Drugs Sales Market Share by Region (2027-2032) Table 51. Global Macrolide Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Macrolide Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Macrolide Drugs Sales Value Share by Region (2021-2026) Table 54. Global Macrolide Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Macrolide Drugs Sales Value Share by Region (2027-2032) Table 56. Global Macrolide Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Macrolide Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Macrolide Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Macrolide Drugs Sales by Country (2021-2026) & (k units) Table 61. Global Macrolide Drugs Sales Market Share by Country (2021-2026) Table 62. Global Macrolide Drugs Sales by Country (2027-2032) & (k units) Table 63. Global Macrolide Drugs Sales Market Share by Country (2027-2032) Table 64. Global Macrolide Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Macrolide Drugs Sales Value Market Share by Country (2021-2026) Table 66. Global Macrolide Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Macrolide Drugs Sales Value Market Share by Country (2027-2032) Table 68. Teva Pharmaceutical Industries Company Information Table 69. Teva Pharmaceutical Industries Business Overview Table 70. Teva Pharmaceutical Industries Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio Table 72. Teva Pharmaceutical Industries Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Macrolide Drugs Product Portfolio Table 77. Sanofi Recent Development Table 78. Merck & Co. Company Information Table 79. Merck & Co. Business Overview Table 80. Merck & Co. Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck & Co. Macrolide Drugs Product Portfolio Table 82. Merck & Co. Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Mylan Macrolide Drugs Product Portfolio Table 87. Mylan Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Pfizer Macrolide Drugs Product Portfolio Table 92. Pfizer Recent Development Table 93. Fresenius Kabi Company Information Table 94. Fresenius Kabi Business Overview Table 95. Fresenius Kabi Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Fresenius Kabi Macrolide Drugs Product Portfolio Table 97. Fresenius Kabi Recent Development Table 98. WOCKHARDT Company Information Table 99. WOCKHARDT Business Overview Table 100. WOCKHARDT Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. WOCKHARDT Macrolide Drugs Product Portfolio Table 102. WOCKHARDT Recent Development Table 103. Tacorolimus Company Information Table 104. Tacorolimus Business Overview Table 105. Tacorolimus Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Tacorolimus Macrolide Drugs Product Portfolio Table 107. Tacorolimus Recent Development Table 108. Sirolimus Company Information Table 109. Sirolimus Business Overview Table 110. Sirolimus Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Sirolimus Macrolide Drugs Product Portfolio Table 112. Sirolimus Recent Development Table 113. Sandoz International Company Information Table 114. Sandoz International Business Overview Table 115. Sandoz International Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Sandoz International Macrolide Drugs Product Portfolio Table 117. Sandoz International Recent Development Table 118. Neo Química Company Information Table 119. Neo Química Business Overview Table 120. Neo Química Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Neo Química Macrolide Drugs Product Portfolio Table 122. Neo Química Recent Development Table 123. Macrolide Pharmaceuticals Company Information Table 124. Macrolide Pharmaceuticals Business Overview Table 125. Macrolide Pharmaceuticals Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio Table 127. Macrolide Pharmaceuticals Recent Development Table 128. Gland Pharmm Company Information Table 129. Gland Pharmm Business Overview Table 130. Gland Pharmm Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Gland Pharmm Macrolide Drugs Product Portfolio Table 132. Gland Pharmm Recent Development Table 133. Eli Lilly & Co. Company Information Table 134. Eli Lilly & Co. Business Overview Table 135. Eli Lilly & Co. Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Eli Lilly & Co. Macrolide Drugs Product Portfolio Table 137. Eli Lilly & Co. Recent Development Table 138. Akorn Company Information Table 139. Akorn Business Overview Table 140. Akorn Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Akorn Macrolide Drugs Product Portfolio Table 142. Akorn Recent Development Table 143. Abbott Laboratories Company Information Table 144. Abbott Laboratories Business Overview Table 145. Abbott Laboratories Macrolide Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Abbott Laboratories Macrolide Drugs Product Portfolio Table 147. Abbott Laboratories Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Macrolide Drugs Distributors List Table 151. Macrolide Drugs Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Macrolide Drugs Product Image Figure 2. Global Macrolide Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Macrolide Drugs Sales (2021-2032) & (k units) Figure 5. Global Macrolide Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Macrolide Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 14-Membered Ring Agents Image Figure 10. 15-Membered Ring Agents Image Figure 11. 16-Membered Ring Agents Image Figure 12. Ketolides Image Figure 13. Global Macrolide Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Macrolide Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Macrolide Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Macrolide Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Macrolide Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Macrolide Drugs Sales Value Share by Type (2021-2032) Figure 19. Clinics Image Figure 20. Hospitalshospital Pharmacies Image Figure 21. Hospitals Image Figure 22. Online Pharmacies Image Figure 23. Retail Pharmacies Image Figure 24. Global Macrolide Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Macrolide Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Macrolide Drugs Sales Volume Share by Application (2021-2032) Figure 27. Global Macrolide Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Macrolide Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Macrolide Drugs Sales Value Share by Application (2021-2032) Figure 30. Global Macrolide Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Macrolide Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Macrolide Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Macrolide Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. North America Macrolide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Macrolide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Macrolide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 41. South America Macrolide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Macrolide Drugs Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Macrolide Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Macrolide Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Macrolide Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Macrolide Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Macrolide Drugs Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Macrolide Drugs Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • 14-Membered Ring Agents
  • 15-Membered Ring Agents
  • 16-Membered Ring Agents
  • Ketolides
Applications
  • Clinics
  • Hospitalshospital Pharmacies
  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Merck & Co.
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • WOCKHARDT
  • Tacorolimus
  • Sirolimus
  • Sandoz International
  • Neo Química
  • Macrolide Pharmaceuticals
  • Gland Pharmm
  • Eli Lilly & Co.
  • Akorn
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Macrolide Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Macrolide Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Macrolide Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Macrolide Drugs Market Dynamics
  1. 2.1 Macrolide Drugs Industry Trends
  2. 2.2 Macrolide Drugs Industry Drivers
  3. 2.3 Macrolide Drugs Industry Opportunities and Challenges
  4. 2.4 Macrolide Drugs Industry Restraints
3 Macrolide Drugs Market by Company
  1. 3.1 Global Macrolide Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Macrolide Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Macrolide Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Macrolide Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Macrolide Drugs Company Ranking (2024-2026)
  6. 3.6 Global Macrolide Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Macrolide Drugs Company Product Type and Application
  8. 3.8 Global Macrolide Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Macrolide Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Macrolide Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Macrolide Drugs Market by Type
  1. 4.1 Macrolide Drugs Type Introduction
  2. 4.1.1 14-Membered Ring Agents
  3. 4.1.2 15-Membered Ring Agents
  4. 4.1.3 16-Membered Ring Agents
  5. 4.1.4 Ketolides
  6. 4.2 Global Macrolide Drugs Sales Volume by Type
  7. 4.2.1 Global Macrolide Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Macrolide Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Macrolide Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Macrolide Drugs Sales Value by Type
  11. 4.3.1 Global Macrolide Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Macrolide Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Macrolide Drugs Sales Value Share by Type (2021-2032)
5 Macrolide Drugs Market by Application
  1. 5.1 Macrolide Drugs Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitalshospital Pharmacies
  4. 5.1.3 Hospitals
  5. 5.1.4 Online Pharmacies
  6. 5.1.5 Retail Pharmacies
  7. 5.2 Global Macrolide Drugs Sales Volume by Application
  8. 5.2.1 Global Macrolide Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Macrolide Drugs Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Macrolide Drugs Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Macrolide Drugs Sales Value by Application
  12. 5.3.1 Global Macrolide Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Macrolide Drugs Sales Value by Application (2021-2032)
  14. 5.3.3 Global Macrolide Drugs Sales Value Share by Application (2021-2032)
6 Macrolide Drugs Regional Sales and Value Analysis
  1. 6.1 Global Macrolide Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Macrolide Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Macrolide Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Macrolide Drugs Sales by Region (2027-2032)
  5. 6.3 Global Macrolide Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Macrolide Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Macrolide Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Macrolide Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Macrolide Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Macrolide Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Macrolide Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Macrolide Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Macrolide Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Macrolide Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Macrolide Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Macrolide Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Macrolide Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Macrolide Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Macrolide Drugs Sales Value Share by Country, 2025 VS 2032
7 Macrolide Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Macrolide Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Macrolide Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Macrolide Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Macrolide Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Macrolide Drugs Sales by Country (2027-2032)
  6. 7.4 Global Macrolide Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Macrolide Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Macrolide Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Macrolide Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Macrolide Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Macrolide Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Macrolide Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Macrolide Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Macrolide Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Macrolide Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Macrolide Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Macrolide Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Macrolide Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Macrolide Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Macrolide Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Macrolide Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Macrolide Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Macrolide Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Macrolide Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Macrolide Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Macrolide Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Macrolide Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Macrolide Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Macrolide Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Macrolide Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Macrolide Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Macrolide Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Macrolide Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Macrolide Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Macrolide Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Macrolide Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Macrolide Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Macrolide Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Macrolide Drugs Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck & Co.
  14. 8.3.1 Merck & Co. Company Information
  15. 8.3.2 Merck & Co. Business Overview
  16. 8.3.3 Merck & Co. Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Macrolide Drugs Product Portfolio
  18. 8.3.5 Merck & Co. Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Macrolide Drugs Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Macrolide Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Macrolide Drugs Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 WOCKHARDT
  38. 8.7.1 WOCKHARDT Company Information
  39. 8.7.2 WOCKHARDT Business Overview
  40. 8.7.3 WOCKHARDT Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 WOCKHARDT Macrolide Drugs Product Portfolio
  42. 8.7.5 WOCKHARDT Recent Developments
  43. 8.8 Tacorolimus
  44. 8.8.1 Tacorolimus Company Information
  45. 8.8.2 Tacorolimus Business Overview
  46. 8.8.3 Tacorolimus Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Tacorolimus Macrolide Drugs Product Portfolio
  48. 8.8.5 Tacorolimus Recent Developments
  49. 8.9 Sirolimus
  50. 8.9.1 Sirolimus Company Information
  51. 8.9.2 Sirolimus Business Overview
  52. 8.9.3 Sirolimus Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sirolimus Macrolide Drugs Product Portfolio
  54. 8.9.5 Sirolimus Recent Developments
  55. 8.10 Sandoz International
  56. 8.10.1 Sandoz International Company Information
  57. 8.10.2 Sandoz International Business Overview
  58. 8.10.3 Sandoz International Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sandoz International Macrolide Drugs Product Portfolio
  60. 8.10.5 Sandoz International Recent Developments
  61. 8.11 Neo Química
  62. 8.11.1 Neo Química Company Information
  63. 8.11.2 Neo Química Business Overview
  64. 8.11.3 Neo Química Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Neo Química Macrolide Drugs Product Portfolio
  66. 8.11.5 Neo Química Recent Developments
  67. 8.12 Macrolide Pharmaceuticals
  68. 8.12.1 Macrolide Pharmaceuticals Company Information
  69. 8.12.2 Macrolide Pharmaceuticals Business Overview
  70. 8.12.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio
  72. 8.12.5 Macrolide Pharmaceuticals Recent Developments
  73. 8.13 Gland Pharmm
  74. 8.13.1 Gland Pharmm Company Information
  75. 8.13.2 Gland Pharmm Business Overview
  76. 8.13.3 Gland Pharmm Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Gland Pharmm Macrolide Drugs Product Portfolio
  78. 8.13.5 Gland Pharmm Recent Developments
  79. 8.14 Eli Lilly & Co.
  80. 8.14.1 Eli Lilly & Co. Company Information
  81. 8.14.2 Eli Lilly & Co. Business Overview
  82. 8.14.3 Eli Lilly & Co. Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio
  84. 8.14.5 Eli Lilly & Co. Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Macrolide Drugs Product Portfolio
  90. 8.15.5 Akorn Recent Developments
  91. 8.16 Abbott Laboratories
  92. 8.16.1 Abbott Laboratories Company Information
  93. 8.16.2 Abbott Laboratories Business Overview
  94. 8.16.3 Abbott Laboratories Macrolide Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Abbott Laboratories Macrolide Drugs Product Portfolio
  96. 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Macrolide Drugs Value Chain Analysis
  2. 9.1.1 Macrolide Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Macrolide Drugs Sales Mode & Process
  6. 9.2 Macrolide Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Macrolide Drugs Distributors
  9. 9.2.3 Macrolide Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst